Gilead, Evoq Therapeutics announce $600M+ collaboration to boost immunotherapies
ANN ARBOR—Evoq Therapeutics Inc., the Ann Arbor-based immune disease drug development firm, and Foster City, Calif.-based Gilead Sciences Inc. (Nasdaq: GILD) have announced a collaboration and licensing agreement to advance …